$AXSM earnings: what history says about next-day moves
How AXSM has reacted before
| Report | Next-day move |
|---|---|
| Aug 2026 | -6.1% |
| May 2026 | +8.3% |
| Feb 2026 | -4.9% |
| Nov 2025 | +0.6% |
| Aug 2025 | +3.4% |
| May 2025 | +3.8% |
| Feb 2025 | -2.3% |
| Aug 2024 | -1.4% |
Median absolute move 3.6% · higher 4 of 8 · n=8
Axsome Therapeutics, Inc reports Q2 2026 revenue surge to $218 million, highlights promising Ovelity demand and pipeline advancements.
How $AXSM has reacted to earnings
| Report | Next-day |
|---|---|
| Aug 2026 | -6.1% |
| May 2026 | +8.3% |
| Feb 2026 | -4.9% |
| Nov 2025 | +0.6% |
| Aug 2025 | +3.4% |
| May 2025 | +3.8% |
| Feb 2025 | -2.3% |
| Aug 2024 | -1.4% |
Base rate (n=8):
- Median absolute next-day move: 3.6%
- Higher next day: 4 of 8
- Biggest up: +8.3%
- Biggest down: -6.1%